Slate Path Capital LP Quant / Systematic

Location: New York, NY

CIK: 0001559706 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value: $2.044B (100.0% shares, 0.0% debt)

Holdings (14)

XLF SELECT SECTOR SPDR TR 14.0%
Value $286M Shares 12,060,000 Share Price $23.73 Est. Cost/Share $23.25 Unrealized @ Report Date —
CHTR CHARTER COMMUNICATIONS INC N 12.0%
Value $245M Shares 750,000 Share Price $327.32 * Est. Cost/Share $214.89 Unrealized @ Report Date +48.2%
ALLY ALLY FINL INC 10.4%
Value $212M Shares 10,420,000 Share Price $20.33 * Est. Cost/Share $14.81 Unrealized @ Report Date +10.8%
— TWITTER INC 9.6%
Value $196M Shares 13,140,000 Share Price $14.95 Est. Cost/Share $15.34 Unrealized @ Report Date —
GDX VANECK VECTORS ETF TR 8.5%
Value $174M Shares 7,645,000 Share Price $22.81 Est. Cost/Share $26.47 Unrealized @ Report Date —
AAP ADVANCE AUTO PARTS INC 7.9%
Value $162M Shares 1,090,000 Share Price $148.26 * Est. Cost/Share $139.38 Unrealized @ Report Date +1.1%
— TIFFANY & CO NEW 7.7%
Value $158M Shares 1,660,000 Share Price $95.30 Est. Cost/Share $95.30 Unrealized @ Report Date —
— TESORO CORP 7.2%
Value $147M Shares 1,815,000 Share Price $81.06 Est. Cost/Share $80.47 Unrealized @ Report Date —
PODD INSULET CORP 6.0%
Value $123M Shares 2,850,000 Share Price $43.09 Est. Cost/Share $33.03 Unrealized @ Report Date +29.9%
— UNITED STATES STL CORP NEW 5.2%
Value $105M Shares 3,115,000 Share Price $33.81 Est. Cost/Share $20.53 Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 5.0%
Value $103M Shares 2,000,000 Share Price $51.25 * Est. Cost/Share $53.05 Unrealized @ Report Date -12.9%
DXCM DEXCOM INC 4.6%
Value $94.86M Shares 1,119,500 Share Price $84.73 * Est. Cost/Share $19.52 Unrealized @ Report Date 0.0%
— MEDICINES CO 1.6%
Value $33.25M Shares 680,000 Share Price $48.90 Est. Cost/Share $48.90 Unrealized @ Report Date —
— SEASPAN CORP 0.2%
Value $3.881M Shares 560,000 Share Price $6.93 Est. Cost/Share $6.93 Unrealized @ Report Date —